Hypertension, hyperlipidaemia and thrombophilia as the most common risk factors for retinal vein occlusion in patients under 50 years
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F24%3A73616238" target="_blank" >RIV/61989592:15110/24:73616238 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/24:10446976 RIV/00098892:_____/24:10157569
Result on the web
<a href="https://biomed.papers.upol.cz/getrevsrc.php?identification=public&mag=bio&raid=3261&type=fin&ver=2" target="_blank" >https://biomed.papers.upol.cz/getrevsrc.php?identification=public&mag=bio&raid=3261&type=fin&ver=2</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5507/bp.2022.036" target="_blank" >10.5507/bp.2022.036</a>
Alternative languages
Result language
angličtina
Original language name
Hypertension, hyperlipidaemia and thrombophilia as the most common risk factors for retinal vein occlusion in patients under 50 years
Original language description
Background and Aims. Cardiovascular (CV) diseases are the most common risk factors (RFs) for retinal vein occlusion (RVO) development in general. The aim of this study was to identify the most frequent causes of RVO in patientsunder 50.Methods. We retrospectively evaluated a group of patients with RVO under 50 years. The parameters of interest included age and sex, RVO type, presence of arterial hypertension (HT), hyperlipidaemia (HLD), diabetes mellitus (DM),congenital thrombophilic disorder (TD), obstructive sleep apnoea syndrome (OSAS), thyroid eye disease (TED), use ofhormone contraception (HC) or hormone replacement therapy (HRT), glaucoma and other potential RFs. Patients withcentral RVO (CRVO), hemi-central RVO (HRVO), branch RVO (BRVO), impending CRVO and combined arterial-venous(AV) occlusion were included.Results. The group consisted of 110 eyes of 103 patients. CV disease was the most common systemic abnormality.55.3% patients had HT, 17.5% had HLD. TD was the third most frequent RF (12.6%). The cohort also included patientswith DM (6.8%), glaucoma (6.8%) and women using HC/HRT (26.2% of female patients). There were isolated cases ofRVO due to retinal vasculitis, intense exercise, antiphospholipid syndrome and COVID-19 pneumonia. None of thepatients had OSAS, TED or a haemato-oncological disease. The etiology remained unexplained in 20.4% patients. Nodifference was observed in RF occurrence between patients with CRVO and HRVO and those with BRVO.Conclusion. The most common systemic abnormality in our cohort was CV disease, especially HT and HLD. The riskfactors for central, hemi-central and branch RVOs were similar.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30207 - Ophthalmology
Result continuities
Project
<a href="/en/project/NU21J-01-00017" target="_blank" >NU21J-01-00017: Early detection of Graves’ Orbitopathy development in patients with thyroid dysfunction and methods for assessing its activity and severity</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
BIOMEDICAL PAPERS-OLOMOUC
ISSN
1213-8118
e-ISSN
1804-7521
Volume of the periodical
168
Issue of the periodical within the volume
1
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
6
Pages from-to
44-49
UT code for WoS article
000849745500001
EID of the result in the Scopus database
2-s2.0-85187724620